Literature DB >> 24481017

Prolonged spontaneous normocalcaemia in pseudohypoparathyroidism from resorption of soft tissue calcium deposits: a cautionary tale.

Erin E Carter1, Gregory Kline.   

Abstract

A 42-year-old man diagnosed with pseudohypoparathyroidism and Albright's hereditary osteodystrophy as an infant was lost to follow-up and remained, unmonitored, on calcitriol and calcium for over 20 years. He presented after having an ST-elevation myocardial infarction. In addition to coronary artery calcifications, he was found to have diffuse subcutaneous and joint calcifications. His calcium, phosphate and parathyroid hormone (PTH) levels were normal, and given the lack of prior documentation in the diagnosis he was instructed to discontinue calcitriol and calcium until further investigations were completed. Despite stopping the medication, his serum calcium remained normal for over 1 year. It was not until 18 months later, when his soft tissue calcium stores were depleted, that he finally developed symptomatic hypocalcaemia and an elevated PTH. This case not only emphasises the importance of long-term follow-up for patients with pseudohypoparathyroidism, but also highlights the potential complications of long-term, unmonitored, calcitriol use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481017      PMCID: PMC3912362          DOI: 10.1136/bcr-2013-202729

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  31 in total

1.  Pseudohypoparathyroidism presenting with bony deformities resembling rickets.

Authors:  Anurag Bajpai; Jyoti Sharma; Pankaj Hari; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2004-04       Impact factor: 1.967

2.  Corrected QT interval (QTc) prolongation and syncope associated with pseudohypoparathyroidism and hypocalcemia.

Authors:  T C Huang; F C Cecchin; P Mahoney; M A Portman
Journal:  J Pediatr       Date:  2000-03       Impact factor: 4.406

3.  Albright's hereditary osteodystrophy with extensive heterotopic ossification of the oral and maxillofacial region: how fetuin research may help a seemingly impossible condition.

Authors:  Marc G DuVal; Sarah Davidson; Andrew Ho; Rachale Cohen; Michael Park; Somayeh Nourian; Gerald Baker; George K B Sándor
Journal:  J Can Dent Assoc       Date:  2007-11       Impact factor: 1.316

4.  Hypersensitivity to intravenous and oral calcitriol with successful desensitization.

Authors:  S Amandeep; B Lomaestro; H J Meuwissen
Journal:  J Allergy Clin Immunol       Date:  1999-01       Impact factor: 10.793

5.  Pseudohypoparathyroidism with paradoxical increase in hypocalcaemic seizures due to long-term anticonvulsant therapy.

Authors:  A Glynne; I P Hunter; J A Thomson
Journal:  Postgrad Med J       Date:  1972-10       Impact factor: 2.401

6.  1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.

Authors:  Charles Henley; Matt Colloton; Russell C Cattley; Edward Shatzen; Dwight A Towler; David Lacey; David Martin
Journal:  Nephrol Dial Transplant       Date:  2005-04-26       Impact factor: 5.992

7.  Early manifestation of obesity and calcinosis cutis in infantile pseudohypoparathyroidism.

Authors:  Preamrudee Poomthavorn; Margaret Zacharin
Journal:  J Paediatr Child Health       Date:  2006-12       Impact factor: 1.954

8.  Pseudopseudohypoparathyroidism with spinal cord compression.

Authors:  C Van Dop; H Wang; R M Mulaikal; V T Tolo; A E Rosenbaum
Journal:  Pediatr Radiol       Date:  1988

9.  Pseudohypoparathyroidism: a series of three cases and an unusual presentation of ocular tetany.

Authors:  R A Sunder; M Singh
Journal:  Anaesthesia       Date:  2006-04       Impact factor: 6.955

10.  Pseudohypoparathyroidism presenting as severe Parkinsonism.

Authors:  D W Pearson; W F Durward; I Fogelman; I T Boyle; G Beastall
Journal:  Postgrad Med J       Date:  1981-07       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.